News
We bring you up to date at all times: Discover the latest industry news from biotechnology, pharmaceuticals and life sciences. Researched by us so you don't have to.
Selected departments
Selected industries
Companies
The Who's Who of Life Sciences: Discover companies from all over the world. Here you can easily find the provider matching your search, including contact options.
Selected countries
Selected companies
Products
The first stop for your procurement process: discover innovative products for lab and process that make your everyday life easier and solve even complex challenges.
Products of selected companies
White papers
What could be better than an application problem that has already been solved by others? Tap into in-depth application knowledge from proven experts. Conveniently via download to your device.
Most read white papers
White papers of selected companies
Webinars
Exciting lectures and practical application tips via video, whenever you want: Our on-demand webinars make it possible. Make yourself comfortable and click play.
Selected webinars
Webinars of selected companies
Knowledge & education
Question. Answer. Find articles on 57,945 keywords in life science, biotech, pharma, biology and related science disciplines in the encyclopedia..
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
Note
The function "Store search" is only available to registered users.
Important information
Currently, you are not logged in to my.bionity.com. Therefore, you can remember a maximum of 5 contents.
FILTER
Refine your search with the following facets to narrow down your results.
End-to-End Single-Site Solution from Drug Substances to Fill-Finish & Packaging
08-Jan-2021 - FUJIFILM Corporation is making an investment of more than 200 Billion yen (2 Billion USD) to establish a new large-scale cell culture production site in the United States to accelerate the growth of its biopharmaceutical contract development and manufacturing business (CDMO). FUJIFILM Diosynth ...
Doubling the drug substance production capacity
15-Jun-2020 - FUJIFILM Corporation will make a major capital investment of approximately 100billion yen(928 million USD)in the Denmark site of FUJIFILM Diosynth Biotechnologies, a leading contract development and manufacturing organization (CDMO) for biologics and advanced therapies. The capital investment ...
22-Dec-2014 - FUJIFILM Diosynth Biotechnologies U.S.A. Inc. (FDBU), a FUJIFILM Corporation subsidiary, announced the completion of its acquisition of Kalon Biotherapeutics LLC, marking an important new chapter in the emergence of the Texas biosciences industry as a center for world-class development and ...
26-Jun-2014 - Fujifilm Diosynth Biotechnologies has announced continued expansion of its process development capabilities with the investment of over US$5.6m in new laboratories and equipment at both its Billingham, UK and Research Triangle Park (RTP), NC, USA sites. This includes the first TAP ambr250™ ...
26-Oct-2012 - Fujifilm Diosynth Biotechnologies has announced it has entered into a strategic alliance with Piramal Healthcare UK Ltd, whereby the two parties will offer the seamless contract development and manufacture of antibody drug conjugates (ADCs), a growing niche in the development of ...
30-Jan-2007 - Diosynth Biotechnology appointed Van Kimmenaede as new president. Van Kimmenaede, who joined Organon in 1986, served as general manager in the UK and in senior management roles in global marketing and manufacturing in Italy, the Netherlands and most recently in New Jersey, USA. On January 1, ...
06-Mar-2006 - Diosynth Biotechnology announced that it has entered into a long-term commercial supply agreement with Dendreon Corporation for the manufacture of the recombinant antigen component of PROVENGE (sipuleucel-T), Dendreon's investigational active cellular immunotherapy for prostate cancer. The ...
26-Sep-2005 - Vernalis Plc has signed a contract with Diosynth Biotechnology for process development, scale-up and manufacturing of V10153 for Phase III clinical trials. The process development and manufacturing agreement will see Vernalis transfer the manufacturing process developed by the company to the ...
© 1997-2024 LUMITOS AG, All rights reserved